Cannabis Markets Primed for Robust Growth as Global Spending Projected to Reach $57 Billion

Cannabis Markets Primed for Robust Growth as Global Spending Projected to Reach $57 Billion
Cannabis Markets Primed for Robust Growth as Global Spending Projected to Reach $57 Billion News Commentary 

The global cannabis industry is in a position to significantly expand and enhance operations as spending is projected to increase drastically over the next decade, according to a study conducted by Arcview Market Research. The study forecasts spending on legal cannabis to near $60 billion by 2027, thus necessitating bolstered operations as industry leaders aim to keep up with the steadily rising global demand. Canada's green rush is on building real excitement that may be attributed to the expected legalization of recreational marijuana in the Country by this coming summer. With expansion nearing, Canadian marijuana growers have been pouring growing amounts of operating cash flow and capital to expand production capacity. Active cannabis stocks in the markets include: Choom™ Holdings Inc.(CSE: CHOO) (OTC: CHOOF), Emblem Corp. (TSX-V: EMC) (OTC: EMMBF), MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF), National Access Clinic Corp. (TSX-V: NAC) (OTC: NACNF), Invictus MD Strategies Corp. (TSX-V: GENE) (OTC: IVITF).

Choom™ Holdings Inc.  (CSE: CHOO) (OTC: CHOOF) BREAKING NEWS:  Choom™ has applied to Saskatchewan Liquor and Gaming Authority ("SLGA") for cannabis retail permits in 32 Zones across the province. The SLGA has made 51 cannabis retail permits available in 32 zones through a Request for Proposal process and is expected to award the permits via lottery by June, 2018.

Additionally, Choom™ has secured the rights to 16 retail locations in Alberta and British Columbia, in all cases, subject to all necessary governmental approvals being granted. This number is excepted to grow over the coming months as the Company is currently negotiating additional leases with the intention of submitting applications for retail licenses.  

"This is a significant step towards delivering the Choom™ experience of 'good times with good friends' for Canadians across the country," states Choom's president and CEO, Chris Bogart. "We have now established a footprint to position Choom™ as a leading private cannabis retailer in Western Canada. We will continue to pursue retail licensing opportunities across the country and remain committed to serving all Canadians in the coming consumer cannabis market. Choom's vision of delivering an elevated customer experience through our curated retail environments, with the creation of modern, stylish storefronts is well underway." Read this and more news for Choom™ at:

Additional industry related developments from around the markets:

Emblem Corp. (TSX-V: EMC.V) (OTC: EMMBF) and Durham College (DC), on behalf of its health and education subsidiary GrowWise Health Limited (GrowWise), are partnering to develop and launch the Cannabis Industry Specialization certification fall 2018. The first of its kind in Ontario, the part-time studies program will be delivered both in class and online via simulcast. It is designed to prepare professionals with business experience or who have already completed a diploma or degree in business to pursue a career in the rapidly growing cannabis sector. "The long-term success of Canada's cannabis industry will depend strongly on there being a skilled workforce to support and advance it," said Adam Saperia, president, GrowWise. "Together, GrowWise and Durham College are ensuring that the right education and training are available to those who are interested in entering this exciting field."

MedReleaf Corp. (TSX: LEAF.TO) (OTC: MEDFF) recently announced the appointments of Umar Syed as Senior Vice President of Corporate Development and Andy Duncan as Vice President of Engineering. In addition to these appointments, Eitan Popper has stepped down from his position as President of MedReleaf, effective immediately. These senior leadership team changes add depth and experience from the pharmaceutical industry as part of MedReleaf's global strategy. Mr. Syed brings over 27 years of experience in the healthcare and pharmaceutical industry and was most recently at Pharmascience Inc., among Canada's largest pharmaceutical companies with distribution in over 60 countries. Mr. Duncan has over 20 years of engineering and infrastructure development experience primarily at Apotex Inc., Canada's largest generic pharmaceutical company with a global operation and exports to over 115 countries.

National Access Clinic Corp. (TSX-V: NAC.V) (OTC: NACNF) and The Second Cup Ltd. ("Second Cup") (SCU.TO), Canada'ssecond-largest retailer of specialty coffee, recently announced that they have established a strategic alliance to develop and operate a network of NAC-branded recreational cannabis dispensaries initially across Western Canada , expanding to include additional provinces where legally permissible. NAC will apply for licenses to dispense cannabis products and upon receipt, work with Second Cup and applicable franchisees to leverage Second Cup's extensive Canadian retail footprint to construct retail stores carrying leading cannabis products, including products supplied by CannaRoyalty Corp. (CSE:CRZ) (OTC: CNNRF) ("CannaRoyalty"), California's largest legal distributor of cannabis products. Conversion of any Second Cup café to an NAC-branded recreational cannabis dispensary will be conditional on obtaining a retail license from provincial regulators and the approval of Second Cup and the applicable franchisee and landlord.

Invictus MD Strategies Corp. (TSX-V: GENE.V) (OTC: IVITF) recently announced that Acreage Pharms Ltd ("Acreage Pharms") has received 23 new strains, providing the Company with a broad cannabis cultivation profile including: strains that are high in CBD; strains that offer especially elevated concentrations of THC; and strains that capture a wide variety of terpenes and cannabinoids, increasingly sought after by cannabis consumers. "The Acreage Pharms team continues to produce more genetics through its selective breeding program to further improve its cultivation biodiversity - a key step towards ensuring the breadth and longevity of our lines for medical and recreational markets," said Invictus Chairman and CEO Dan Kriznic. "Cultivating a generous suite of high-quality cannabis is complex, demanding work. It requires savviness in fields like plant biology, irrigation and lighting, as well as an intimate understanding of pests and diseases and how to vanquish them naturally - no pesticides or herbicides. Acreage Pharms is taking so many smart steps, and of course the team led by Acreage Pharms CEO Trevor Dixon , continues to invest in new strains and will continue to do so across this historic year and beyond. It is thrilling.".


Please see full disclaimers at applicable to all content provided by TSI, wherever published or re-published:

Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. This is a native advertisement, meaning it is an informational paid marketing piece. (TSI) makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. TSI receives payments ranging from approximately $25,000 to $150,000 to publish and/or distribute advertisements on behalf of a company. TSI retains any excess sums after expenses as its compensation. and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. may be paid for services using options or free-trading shares. and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors; will not advise when it or its affiliates decide to sell. Investors must make all investment decisions based on their own judgment of the market and the particular securities.

This advertorial contains forward-looking statements that involve risks and uncertainties. This advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s),” “will,” “make,” “told,” “could,” “might,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein are forward-looking statements as defined in Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business, financing, business trends, future operating revenues and expenses. There can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the company, or contained in this advertorial are not guarantees of future performance, and that the issuer’s actual results may differ materially from those set forth in the forward-looking statements. We undertake no obligation to update any statements made herein except as required by law. Differences in results can be caused by various factors including, but not limited to, the company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains “forward-looking statements.” Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. More information on the company may be found at where readers can review all public filings submitted by the company. is not a certified financial analyst or licensed in the securities industry in any manner. The information in this advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest.


Why Retail Cannabis Could Be the Next Big Investment Boom

Read More